Keros Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -15.28 | -100% |
| P/S |
|
7847.36 | 33.76 | 23146.31% |
|
|
| P/BV |
|
3.57 | 4.82 | -26.01% |
|
|
| P/FCF |
|
-10 | 61 | -116.4% |
|
|
| Ev/Ebitda |
|
-5.2 | -22.15 | -76.52% |
|
|
| Ev/S |
|
5749.99 | 22.56 | 25383.02% |
|
|
| Ev/FCF |
|
-6.84 | 68.78 | -109.94% |
|
|
| E/P |
|
-0.1205 | 0.0178 | -777.97% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-110550.99 | 4.98 | -2221364.78% | -20699.21 | +434.08% |
| ROE |
|
-46.05 | 9.61 | -579.13% |
|
|
| ROA |
|
-41.35 | 0.3443 | -12110.24% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-101319.21 | -25.17 | 402438.84% |
|
|
| ROCE |
|
-50.49 | 15.35 | -428.94% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0865 | -3.68 | -97.65% | -0.0832 | +4.01% |
| Nеt Debt/Ebitda |
|
1.9 | -3.44 | -155.2% |
|
|
| Debt/Ratio |
|
0.039 | 0.1985 | -80.33% |
|
|
| Debt/Equity |
|
7.22 | 1.66 | 334.47% |
|
|
| Debt/Net Income |
|
-0.0944 | 10.32 | -100.91% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5442 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2237 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9889 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4952 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5442 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-98.49 | -56.89 | 73.12% | ||
| Growth impulse Ebitda in 5 years |
|
1453.3 | -54.68 | -2757.83% | ||
| Growth impulse Net Income in 5 years |
|
943.67 | -58.33 | -1717.81% | ||
| Growth impulse FCF in 5 years |
|
680.45 | -49.48 | -1475.2% | ||
| Growth impulse EPS in 5 years |
|
544.67 | -32.41 | -1780.56% |
IP Score
3.68/10
